325 - Aspargo Labs

GOAL

Create the Aspargo brand to convey its inherent value and credibility to garner funding opportunities.

SOLUTION

325 developed the core identity to shape investor perception from a position of strength, confidence and masculinity as Sildenafil Oral Spray is a proven drug and Aspargo Labs proposes a novel delivery system for the drug to men with ED.

Fueling trustworthiness and interest, 325 developed mission-critical assets. The Aspargo website amplified stakeholder value messaging and a high-quality corporate deck clearly communicated the company’s strategy aligned with short- and longer-term business model, timeline charts and showcased the company’s management.

DELIVERABLES

BRAND STRATEGY
CORPORATE IDENTITY
WEBSITE DESIGN + DEVELOPMENT
INVESTOR PRESENTATION
STATIONERY
BRAND GUIDELINES

STRATEGY

Through discovery 325 immersed itself into understanding the mission, values and vision for the brand. Coupled with market research, 325 differentiated the brand to propel it forward to engage investors and funding resources. Strong, powerful, masculine, bold in tone, delivery and messaging aligning with same in palette, typography and visual elements, the Aspargo brand came to life. Brand guidelines were developed to ensure the new identity and messaging remain consistent throughout internal and external uses.

Design and development of the website sought to educate audiences immediately to generate interest and engagement, establish credibility and viability by driving home Aspargo’s proven technology, market exclusivity and protected IP and commercialization plan to align brand and stakeholder success.

325 tailored the brand to prepare for the ask by creating a high-quality corporate deck that communicated professionalism and success. We developed the deck to be straightforward, succinct, confident and clear to provide a complete and realistic view of the company’s fundamentals, challenges and objectives with market size, competitive situation, industry dynamics, success measurements. A tight message was delivered quickly and powerfully.

ABOUT ASPARGO LABS

Aspargo Laboratories, Inc. is a clinical-stage biopharmaceutical company developing patient-focused solutions and must-have medicines by combining our innovative science and technologies with FDA’s 505(b)(2) approval pathway and corresponding regulations in international jurisdictions to enhance currently marketed drugs with well-known pharmacology profiles.